Literature DB >> 26033031

Upregulated PFTK1 promotes tumor cell proliferation, migration, and invasion in breast cancer.

Xiaoling Gu1, Yingying Wang, Hua Wang, Qichao Ni, Chunhui Zhang, Jia Zhu, Wei Huang, Pan Xu, Guoxin Mao, Shuyun Yang.   

Abstract

PFTK1 was a cell division cycle 2-related serine/threonine protein kinase, which was up-regulated in breast cancer tissues and breast cancer lines. And up-regulated PFTK1 was highly associated with grade, axillary lymph node status, and Ki-67. Moreover, Kaplan-Meier curve showed that up-regulated PFTK1 was related to the poor breast carcinoma patients' overall survival. Here, we first discovered and confirmed that cyclin B was a new interacting protein of PFTK1, and the complex might increase the amount of DVL2, which triggers Wnt/β-catenin signaling pathway. Furthermore, knockdown of PFTK1 attenuated cell proliferation, anchorage-independent cell growth, and cell migration and invasion by inhibiting the transcriptional activation of β-catenin for cyclin D1, MMP9, and HEF1, whereas exogenous expression of PFTK1 might promote MDA-MB-231 cells proliferation, migration, and invasion via promoting PFTK1-DVL2-β-catenin axis. Our findings supported the notion that up-regulated PFTK1 might promote breast cancer progression and metastasis by activating Wnt signaling pathway through the PFTK1-DVL2-β-catenin axis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26033031     DOI: 10.1007/s12032-015-0641-8

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  34 in total

1.  KIF3a promotes proliferation and invasion via Wnt signaling in advanced prostate cancer.

Authors:  Zun Liu; Ryan E Rebowe; Zemin Wang; Yingchun Li; Zehua Wang; John S DePaolo; Jianhui Guo; Chiping Qian; Wanguo Liu
Journal:  Mol Cancer Res       Date:  2014-01-10       Impact factor: 5.852

2.  Interaction of axin and Dvl-2 proteins regulates Dvl-2-stimulated TCF-dependent transcription.

Authors:  M J Smalley; E Sara; H Paterson; S Naylor; D Cook; H Jayatilake; L G Fryer; L Hutchinson; M J Fry; T C Dale
Journal:  EMBO J       Date:  1999-05-17       Impact factor: 11.598

3.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

Review 4.  Role of matrix metalloproteinases (MMPs) in colorectal cancer.

Authors:  Stanley Zucker; Jeffrey Vacirca
Journal:  Cancer Metastasis Rev       Date:  2004 Jan-Jun       Impact factor: 9.264

5.  HEF1 is a crucial mediator of the proliferative effects of prostaglandin E(2) on colon cancer cells.

Authors:  Dianren Xia; Vijaykumar R Holla; Dingzhi Wang; David G Menter; Raymond N DuBois
Journal:  Cancer Res       Date:  2010-01-12       Impact factor: 12.701

6.  The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer.

Authors:  Yan Ni Loh; Ellen L Hedditch; Laura A Baker; Eve Jary; Robyn L Ward; Caroline E Ford
Journal:  BMC Cancer       Date:  2013-04-02       Impact factor: 4.430

7.  Therapeutic implications of targeting energy metabolism in breast cancer.

Authors:  Meena K Sakharkar; Babita Shashni; Karun Sharma; Sarinder K Dhillon; Prabhakar R Ranjekar; Kishore R Sakharkar
Journal:  PPAR Res       Date:  2013-02-03       Impact factor: 4.964

8.  Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells.

Authors:  Craig A Cooney; Fariba Jousheghany; Aiwei Yao-Borengasser; Bounleut Phanavanh; Tina Gomes; Ann Marie Kieber-Emmons; Eric R Siegel; Larry J Suva; Soldano Ferrone; Thomas Kieber-Emmons; Behjatolah Monzavi-Karbassi
Journal:  Breast Cancer Res       Date:  2011-06-09       Impact factor: 6.466

9.  Numbl inhibits glioma cell migration and invasion by suppressing TRAF5-mediated NF-κB activation.

Authors:  Tao Tao; Chun Cheng; Yuhong Ji; Guangfei Xu; Jianguo Zhang; Li Zhang; Aiguo Shen
Journal:  Mol Biol Cell       Date:  2012-05-16       Impact factor: 4.138

Review 10.  The changing global patterns of female breast cancer incidence and mortality.

Authors:  Freddie Bray; Peter McCarron; D Maxwell Parkin
Journal:  Breast Cancer Res       Date:  2004-08-26       Impact factor: 6.466

View more
  13 in total

1.  Activity-Based Protein Profiling Shows Heterogeneous Signaling Adaptations to BRAF Inhibition.

Authors:  Ritin Sharma; Inna Fedorenko; Paige T Spence; Vernon K Sondak; Keiran S M Smalley; John M Koomen
Journal:  J Proteome Res       Date:  2016-11-17       Impact factor: 4.466

2.  The role of lncRNA MSC-AS1/miR-29b-3p axis-mediated CDK14 modulation in pancreatic cancer proliferation and Gemcitabine-induced apoptosis.

Authors:  Yunpeng Sun; Pengfei Wang; Wenjun Yang; Yunfeng Shan; Qiyu Zhang; Huanhuan Wu
Journal:  Cancer Biol Ther       Date:  2019-03-27       Impact factor: 4.742

3.  The anti-tumor effect of miR-539-3p on colon cancer via regulating cell viability, motility, and nude mouse tumorigenicity with CDK14 inhibition.

Authors:  Zhuo Wang; Tao Hu; Chengwu Jin; Jiangui Yu; Dongqiang Zhu; Jian Liu
Journal:  J Gastrointest Oncol       Date:  2020-10

4.  Downregulation of PFTK1 Inhibits Migration and Invasion of Non-Small Cell Lung Cancer.

Authors:  Mei Jiang; Qi Chen; Xiaoting Zhao; Yu Teng; Chenghong Yin; Wentao Yue
Journal:  Onco Targets Ther       Date:  2020-09-22       Impact factor: 4.147

5.  Knockdown of PFTK1 inhibits tumor cell proliferation, invasion and epithelial-to-mesenchymal transition in pancreatic cancer.

Authors:  Li Zheng; Zhongyong Zhou; Zhikuan He
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

6.  CDK14 involvement in proliferation migration and invasion of esophageal cancer.

Authors:  Lingling Chen; Yayun Wang; Wenyan Jiang; Runzhou Ni; Yuchan Wang; Sujie Ni
Journal:  Ann Transl Med       Date:  2019-11

7.  Multi-view based integrative analysis of gene expression data for identifying biomarkers.

Authors:  Zi-Yi Yang; Xiao-Ying Liu; Jun Shu; Hui Zhang; Yan-Qiong Ren; Zong-Ben Xu; Yong Liang
Journal:  Sci Rep       Date:  2019-09-18       Impact factor: 4.379

8.  Identification of key genes and pathways downstream of the β-catenin-TCF7L1 complex in pancreatic cancer cells using bioinformatics analysis.

Authors:  Yi-Hang Yuan; Jian Zhou; Yan Zhang; Meng-Dan Xu; Jing Wu; Wei Li; Meng-Yao Wu; Dao-Ming Li
Journal:  Oncol Lett       Date:  2019-06-06       Impact factor: 2.967

9.  Downregulation of dual-specificity tyrosine-regulated kinase 2 promotes tumor cell proliferation and invasion by enhancing cyclin-dependent kinase 14 expression in breast cancer.

Authors:  Yoshimi Imawari; Rei Mimoto; Shinichi Hirooka; Toshiaki Morikawa; Hiroshi Takeyama; Kiyotsugu Yoshida
Journal:  Cancer Sci       Date:  2018-01-13       Impact factor: 6.716

10.  miR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14.

Authors:  Quanbo Ji; Xiaojie Xu; Ling Li; Stuart B Goodman; Wenzhi Bi; Meng Xu; Yameng Xu; Zhongyi Fan; William J Maloney; Qinong Ye; Yan Wang
Journal:  Cell Death Dis       Date:  2017-10-12       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.